News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
780,376 Results
Type
Article (55498)
Company Profile (405)
Press Release (724455)
Multimedia
Podcasts (193)
Webinars (27)
Section
Business (218190)
Career Advice (2914)
Deals (38217)
Drug Delivery (152)
Drug Development (87336)
Employer Resources (184)
FDA (17771)
Job Trends (16066)
News (372070)
Policy (35853)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2712)
Academic (1)
Accelerated approval (38)
Adcomms (36)
Allergies (154)
Alliances (54679)
ALS (185)
Alzheimer's disease (1800)
Antibody-drug conjugate (ADC) (363)
Approvals (17969)
Artificial intelligence (625)
Autoimmune disease (185)
Automation (46)
Bankruptcy (382)
Best Places to Work (11939)
BIOSECURE Act (23)
Biosimilars (211)
Biotechnology (248)
Bladder cancer (169)
Brain cancer (65)
Breast cancer (667)
Cancer (5157)
Cardiovascular disease (452)
Career advice (2473)
Career pathing (42)
CAR-T (315)
CDC (66)
Celiac Disease (1)
Cell therapy (841)
Cervical cancer (38)
Clinical research (74348)
Collaboration (1906)
Company closure (5)
Compensation (1219)
Complete response letters (77)
COVID-19 (2923)
CRISPR (102)
C-suite (937)
Cystic fibrosis (152)
Data (6483)
Decentralized trials (2)
Denatured (65)
Depression (156)
Diabetes (526)
Diagnostics (6904)
Digital health (49)
Diversity (13)
Diversity, equity & inclusion (45)
Drug discovery (291)
Drug pricing (229)
Drug shortages (35)
Duchenne muscular dystrophy (254)
Earnings (92492)
Editorial (69)
Employer branding (22)
Employer resources (162)
Events (125869)
Executive appointments (1054)
FDA (21074)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (12)
Frontotemporal dementia (25)
Funding (1581)
Gene editing (219)
Generative AI (57)
Gene therapy (679)
GLP-1 (1147)
Government (4748)
Grass and pollen (8)
Guidances (387)
Healthcare (19021)
HIV (68)
Huntington's disease (53)
IgA nephropathy (89)
Immunology and inflammation (305)
Immuno-oncology (72)
Indications (125)
Infectious disease (3235)
Inflammatory bowel disease (215)
Inflation Reduction Act (17)
Influenza (129)
Intellectual property (265)
Interviews (530)
IPO (17349)
IRA (61)
Job creations (4482)
Job search strategy (2050)
JPM (72)
Kidney cancer (18)
Labor market (93)
Layoffs (648)
Leadership (42)
Legal (8919)
Liver cancer (98)
Longevity (18)
Lung cancer (691)
Lymphoma (390)
Machine learning (45)
Management (63)
Manufacturing (896)
MASH (180)
Medical device (14257)
Medtech (14315)
Mergers & acquisitions (21976)
Metabolic disorders (1434)
mRNA (195)
Multiple sclerosis (176)
NASH (23)
Neurodegenerative disease (364)
Neuropsychiatric disorders (106)
Neuroscience (3178)
Neurotech (1)
NextGen: Class of 2026 (6920)
Non-profit (4347)
Now hiring (68)
Obesity (712)
Opinion (338)
Ovarian cancer (172)
Pain (221)
Pancreatic cancer (244)
Parkinson's disease (310)
Partnered (35)
Patents (539)
Patient recruitment (533)
Peanut (61)
People (63713)
Pharmaceutical (111)
Pharmacy benefit managers (34)
Phase 1 (23068)
Phase 2 (32506)
Phase 3 (24576)
Pipeline (5779)
Policy (352)
Postmarket research (2913)
Preclinical (9743)
Press Release (70)
Prostate cancer (265)
Psychedelics (60)
Radiopharmaceuticals (311)
Rare diseases (971)
Real estate (6820)
Recruiting (74)
Regulatory (27082)
Reports (54)
Research institute (2538)
Resumes & cover letters (457)
Rett syndrome (28)
RNA editing (20)
RSV (89)
Schizophrenia (163)
Series A (272)
Series B (205)
Service/supplier (20)
Sickle cell disease (108)
Special edition (28)
Spinal muscular atrophy (172)
Sponsored (48)
Startups (4062)
State (2)
Stomach cancer (21)
Supply chain (115)
Tariffs (101)
The Weekly (126)
Vaccines (1169)
Venture capital (101)
Weight loss (489)
Women's health (99)
Worklife (22)
Date
Today (199)
Last 7 days (807)
Last 30 days (2840)
Last 365 days (31822)
2026 (4792)
2025 (32049)
2024 (36894)
2023 (41668)
2022 (52763)
2021 (57291)
2020 (55713)
2019 (48194)
2018 (36488)
2017 (34978)
2016 (35412)
2015 (41029)
2014 (35597)
2013 (30186)
2012 (32168)
2011 (32479)
2010 (31105)
Location
Africa (953)
Alabama (95)
Alaska (7)
Arizona (337)
Arkansas (14)
Asia (46718)
Australia (7583)
California (11829)
Canada (3357)
China (1206)
Colorado (491)
Connecticut (516)
Delaware (354)
Europe (105758)
Florida (1762)
Georgia (381)
Hawaii (4)
Idaho (68)
Illinois (955)
India (75)
Indiana (557)
Iowa (22)
Japan (455)
Kansas (129)
Kentucky (44)
Louisiana (26)
Maine (82)
Maryland (1469)
Massachusetts (8623)
Michigan (353)
Minnesota (658)
Mississippi (6)
Missouri (136)
Montana (35)
Nebraska (29)
Nevada (127)
New Hampshire (83)
New Jersey (3164)
New Mexico (31)
New York (3112)
North Carolina (1598)
North Dakota (10)
Northern California (5757)
Ohio (354)
Oklahoma (20)
Oregon (46)
Pennsylvania (2328)
Puerto Rico (25)
Rhode Island (50)
South America (1371)
South Carolina (70)
South Dakota (1)
Southern California (4615)
Tennessee (181)
Texas (1833)
United States (42279)
Utah (342)
Vermont (1)
Virginia (291)
Washington D.C. (86)
Washington State (960)
West Virginia (4)
Wisconsin (133)
Wyoming (2)
780,376 Results for "biopharma solutions baxter s pharma biotech partnering business".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Mergers & acquisitions
At JPM26, Policy and Politics Will Loom Large for Pharma as Biotech Sees the Sun
Pharmas will need to provide their latest stance on the Most Favored Nation drug pricing plans, while biotech finally gets a break after a few tough years.
January 9, 2026
·
4 min read
·
Annalee Armstrong
Mergers & acquisitions
6 Biotechs That Could Be Big Pharma’s Next M&A Target
Metsera showed the biopharma world that M&A is back. Who could be next?
December 17, 2025
·
8 min read
·
Annalee Armstrong
Insights
Five Trends That Got Everyone Talking in Pharma and Biotech This Year
In 2025, landmark obesity drug deals, China’s biotech surge, and AI’s deeper integration into pharma operations drove a year of transformation and renewed momentum for life sciences.
November 12, 2025
·
5 min read
·
Jennifer Smith-Parker
Press Releases
Rentschler Biopharma and Coriolis Pharma announce strategic collaboration for integrated biopharma solutions
December 2, 2025
·
5 min read
Press Releases
Zenas BioPharma to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026
February 4, 2026
·
2 min read
Collaboration
JPM26: BMS’s Early-Stage Bets Are Happening Now, Amid Pharma’s Late-Stage Frenzy
Mature biopharma deals are stealing all the headlines, but Bristol Myers Squibb’s Robert Plenge says the company’s deals with insitro, Orbital and more are building the future.
January 12, 2026
·
3 min read
·
Annalee Armstrong
Press Releases
Zenas BioPharma’s Partner, InnoCare Pharma, Announces Achievement of Primary Endpoint in Phase 2b Study of Orelabrutinib, a BTK Inhibitor, for Systemic Lupus Erythematosus
December 15, 2025
·
10 min read
Job Trends
Increasingly Competitive Job Market Worries, Frustrates Biopharma Professionals
Competition for biotech and pharma employment picked up year over year and remains strong, according to
BioSpace
data. A survey late last year showed that 64% of employed/contract and 96% of unemployed respondents will actively look for work in 2026.
January 22, 2026
·
5 min read
·
Angela Gabriel
Drug pricing
Despite MFN Deals, Drug Pricing Will Dog Pharma Into 2026
Only a handful of the top pharmas have signed Most Favored Nation drug pricing deals with the White House, while smaller biotechs continue to hang in limbo.
January 6, 2026
·
5 min read
·
Annalee Armstrong
Policy
Acadia CEO Bands With Peers To Lobby Against MFN Drug Pricing for Small Biotech
Acadia Pharma’s Catherine Owen Adams is one of the founders of a group of small- to mid-cap biotechs advocating against a ‘peanut butter blanket’ approach to drug pricing for small companies.
January 13, 2026
·
3 min read
·
Annalee Armstrong
1 of 78,038
Next
